Paper22246735
Biotherapeutic formulation factors affecting metal leachables from stainless steel studied by design of experiments.
Zhou S and 3 others. AAPS PharmSciTech, 2012. Cited by 35 papers, by iCite.
Cite this record
ConductScience Library. Biotherapeutic formulation factors affecting metal leachables from stainless steel studied by design of experiments. Papers, record 22246735. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22246735
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Biotherapeutic formulation factors affecting metal leachables from stainless steel studied by design of experiments.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biological Therapy | Major topic |
| Chemistry, Pharmaceutical | Major topic |
| Drug Contamination | Major topic |
| Metals | Major topic |
| Stainless Steel | Major topic |
| Drug Storage |
Source PubMed
References19
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16998873 | Antibody structure, instability, and formulation. | J Pharm Sci | 2007 | https://conductscience.org/library/papers/16998873 | PubMed |
| 2 | 8124728 | The development of stable protein formulations: a close look at protein aggregation, deamidation, and oxidation. | Crit Rev Ther Drug Carrier Syst | 1993 | https://conductscience.org/library/papers/8124728 | PubMed |
| 3 | 15348541 | The influence of complexing agent and proteins on the corrosion of stainless steels and their metal components. | J Mater Sci Mater Med | 2003 | https://conductscience.org/library/papers/15348541 | PubMed |
| 4 | 10754542 | The formulation of biopharmaceutical products. | Pharm Sci Technol Today | 2000 | https://conductscience.org/library/papers/10754542 | PubMed |
| 5 | 21360314 | Biologics formulation factors affecting metal leachables from stainless steel. | AAPS PharmSciTech | 2011 | https://conductscience.org/library/papers/21360314 | PubMed |
| 6 | 3753454 | Site-specific modification of albumin by free radicals. Reaction with copper(II) and ascorbate. | Biochem J | 1986 | https://conductscience.org/library/papers/3753454 | PubMed |
| 7 | 8300566 | Identification of oxidized histidine generated at the active site of Cu,Zn-superoxide dismutase exposed to H2O2. Selective generation of 2-oxo-histidine at the histidine 118. | J Biol Chem | 1994 | https://conductscience.org/library/papers/8300566 | PubMed |
| 8 | 20039442 | Impact of freezing on pH of buffered solutions and consequences for monoclonal antibody aggregation. | Biotechnol Prog | 2010 | https://conductscience.org/library/papers/20039442 | PubMed |
| 9 | 7358745 | Electrochemical corrosion in saline and serum. | J Biomed Mater Res | 1980 | https://conductscience.org/library/papers/7358745 | PubMed |
| 10 | 11852692 | Stabilization of pharmaceuticals to oxidative degradation. | Pharm Dev Technol | 2002 | https://conductscience.org/library/papers/11852692 | PubMed |
| 11 | 7727437 | Aggregation and precipitation of human relaxin induced by metal-catalyzed oxidation. | Biochemistry | 1995 | https://conductscience.org/library/papers/7727437 | PubMed |
| 12 | 6699034 | Isolation of serum protein organometallic corrosion products from 316LSS and HS-21 in vitro and in vivo. | J Biomed Mater Res | 1984 | https://conductscience.org/library/papers/6699034 | PubMed |
| 13 | 19230018 | Precipitation of a monoclonal antibody by soluble tungsten. | J Pharm Sci | 2009 | https://conductscience.org/library/papers/19230018 | PubMed |
| 14 | 8563639 | How to measure and predict the molar absorption coefficient of a protein. | Protein Sci | 1995 | https://conductscience.org/library/papers/8563639 | PubMed |
| 15 | 20737631 | Comparative evaluation of disodium edetate and diethylenetriaminepentaacetic acid as iron chelators to prevent metal-catalyzed destabilization of a therapeutic monoclonal antibody. | J Pharm Sci | 2010 | https://conductscience.org/library/papers/20737631 | PubMed |
| 16 | 2283087 | Metal ion-catalyzed oxidation of proteins: biochemical mechanism and biological consequences. | Free Radic Biol Med | 1990 | https://conductscience.org/library/papers/2283087 | PubMed |
| 17 | 11553618 | Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure. | J Biol Chem | 2001 | https://conductscience.org/library/papers/11553618 | PubMed |
| 18 | 16839640 | Formulation and delivery issues for monoclonal antibody therapeutics. | Adv Drug Deliv Rev | 2006 | https://conductscience.org/library/papers/16839640 | PubMed |
| 19 | 9279875 | Rational design of stable lyophilized protein formulations: some practical advice. | Pharm Res | 1997 | https://conductscience.org/library/papers/9279875 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 35 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41300272 | Heavy Metal Contamination in Adaptogenic Herbal Dietary Supplements: Experimental, Assessment and Regulatory Safety Perspectives. | Biology (Basel) | 2025 | https://conductscience.org/library/papers/41300272 | PubMed |
| 38937372 | Stability of Protein Pharmaceuticals: Recent Advances. | Pharm Res | 2024 | https://conductscience.org/library/papers/38937372 | PubMed |
| 37680877 | Oxidation of polysorbates - An underestimated degradation pathway? | Int J Pharm X | 2023 | https://conductscience.org/library/papers/37680877 | PubMed |
| 37334968 | Development and biophysical characterization of a humanized FSH-blocking monoclonal antibody therapeutic formulated at an ultra-high concentration. | Elife | 2023 | https://conductscience.org/library/papers/37334968 | PubMed |
| 37032437 | Determination of ultra-trace metal-protein interactions in co-formulated monoclonal antibody drug product by SEC-ICP-MS. | MAbs | 2023 | https://conductscience.org/library/papers/37032437 | PubMed |
| 34382142 | Metal Ion Interactions with mAbs: Part 2. Zinc-Mediated Aggregation of IgG1 Monoclonal Antibodies. | Pharm Res | 2021 | https://conductscience.org/library/papers/34382142 | PubMed |
| 31156028 | Rapid global characterization of immunoglobulin G1 following oxidative stress. | MAbs | 2019 | https://conductscience.org/library/papers/31156028 | PubMed |
| 31101998 | Differentiating the Effects of Oxidative Stress Tests on Biopharmaceuticals. | Pharm Res | 2019 | https://conductscience.org/library/papers/31101998 | PubMed |
| 23412915 | Fluorogenic tagging methodology applied to characterize oxidized tyrosine and phenylalanine in an immunoglobulin monoclonal antibody. | Pharm Res | 2013 | https://conductscience.org/library/papers/23412915 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/22246735
GET https://conductscience.org/api/papers/v1/22246735/authors